Clariant

Clariant concentrates on customer benefits at CPhI Worldwide 2014

  • Broad portfolio backed by strong support for the pharmaceutical industry on display in Hall 5 Booth 5R77
  • Effective and efficient high-purity ingredients
  • Controlled atmosphere packaging for protection against moisture and oxygen

Muttenz, October 8, 2014 - Clariant, a world leader in specialty chemicals, will be at CPhI Worldwide 2014 to demonstrate how its commitment to collaborating closely with customers in the pharmaceutical industry can deliver effective and efficient innovations. The annual CPhI Worldwide exhibition this year takes place in Paris on October 7-9, and Clariant will be in Hall 5, Stand 5R77.

By understanding customer needs and expectations, Clariant’s Consumer Care Business is able to offer comprehensive and viable solutions to increase efficiency, reduce costs and improve the environmental compatibility of products. The company will present innovative, sustainable and trend-based products to support the changing needs of the pharmaceutical market.

High-purity ingredients include Polyglykol, a range of universally applicable pharmaceutical polymers suitable for a vast range of applications in the healthcare sector. Clariant’s broad portfolio features pharmaceutical polyethylene glycols (PEGs, or Macrogols), which are used as APIs (active pharmaceutical ingredients) in laxatives and as excipients for tablets, suppository masses, organ preservation, protein purification and drug delivery systems. They dissolve easily in water, and they are non-toxic and non-irritant, making them particularly versatile. Clariant offers a complete range of Macrogols with various molecular weights, all of them with high purity and supported by CEP certification and DMF.

In addition, Clariant will feature packaging solutions to support the pharmaceutical industry in maintaining drug stability and extending shelf life. Clariant Healthcare Packaging designs and manufactures controlled atmosphere packaging that helps to protect healthcare products from humidity and oxygen. Its broad portfolio includes industry-leading desiccant canisters and packets; tubes and desiccant stoppers; IDC® Integrated Desiccant Closure; ADP® Advanced Desiccant Polymer; EQ-Pak® humidity regulators; PharmaKeep®1 oxygen scavengers; Oxy-Guard® barrier bottles; and specially engineered dispensers.

In the spotlight at CPhI: Tubairless®2, an innovative airless packaging system for protecting and dispensing sensitive pharmaceutical semi-solids and creams. Tubairless helps to protect sensitive formulas from contamination because the tube’s internal pump prevents air-intake or product flow back, promoting increased product hygiene. Packaging keeps its original shape, integrity and legibility, while product waste is minimized with greater than 95% evacuation.

For more information, visit Clariant at CPhI Hall 5 Booth 5R77 & 2k53.

Reader enquiries

Clariant International Ltd
Rothausstrasse 61
4132 Muttenz 1
Switzerland

+41 61 469 6742

www.clariant.com

@clariant

Clariant

ClariantInternational

clariant_international


Notes for editors


®1 = TRADEMARK OF MITSUBISHI CHEMICALS

®2 = TRADEMARK OF PUMPART SYSTEM

® TRADEMARK OF CLARIANT REGISTERED IN MANY COUNTRIES

www.clariant.com

Clariant is a globally leading specialty chemicals company, based in Muttenz near Basel/Switzerland. On December 31, 2013 the company employed a total workforce of 18,099. In the financial year 2013, Clariant recorded sales of CHF 6.076 billion for its continuing businesses. The company reports in four business areas: Care Chemicals, Catalysis & Energy, Natural Resources, and Plastics & Coatings. Clariant’s corporate strategy is based on five pillars: increase profitability, reposition portfolio, add value with sustainability, foster innovation and R&D, and intensify growth.

Editorial enquiries

Carsten Seum
Clariant International Ltd

+41 61 469 63 63

carsten.seum@​clariant.com

Stefanie Nehlsen
Clariant International Ltd

+41 61 469 63 63

stefanie.nehlsen@​clariant.com

Josina van der Velden
EMG

+31 164 317 014

jvandervelden@​emg-marcom.com

 

Share

 

More news from